首页> 外文期刊>International journal of STD & AIDS >The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients.
【24h】

The outcome of treatment of early latent syphilis and syphilis with undetermined duration in HIV-infected and HIV-uninfected patients.

机译:HIV感染者和HIV未感染者早期潜伏梅毒和持续时间不确定的梅毒的治疗结果。

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of the study was to compare the outcome of syphilis treatment in HIV-infected and -uninfected patients. An observational study on patients diagnosed with early syphilis in three genitourinary clinics in the UK between January 2003 and June 2005 was conducted. Failure of the initial Venereal Disease Research Laboratory (test) (VDRL) titre to decrease four-fold within 12 months in the absence of history of re-infection was considered as treatment failure. During the study period, 190 HIV-uninfected and 129 HIV-infected patients were diagnosed, and 161 (84%) HIV-uninfected and 100 (77.5%) HIV-positive patients with diagnosis of syphilis who had 24 months follow-up syphilis serology results were included in the study (P = 0.10). There were 381 and 508 follow-up episodes for HIV-infected and -uninfected patients, respectively, within 24 months. One HIV-infected patient was diagnosed with neuro-syphilis. After 12 months, 102 (63%) HIV-uninfected and 76 (70%) HIV-infected patients were treated (P = 0.04). On Cox proportional hazard model, successful treatment after 12 months was associated with having VDRL titre more than 1:6 (hazard ratio [HR] 1.011; 95% confidence interval [CI], 1.004-1.019; P = 0.002). Those with negative immunoglobulin M enzyme immunoassay were less likely to have been successfully treated after 12 months (HR 0.676 [95% CI 0.518-0.883]; P = 0.004). HIV sero-status, age, sex group and treatment regimen were not associated with success of treatment. In conclusion, HIV sero-status did not play a role in the outcome of syphilis treatment. Treatment failure in a proportion of HIV-infected patients is due to a slower decline in VDRL titre rather than lack of response to treatment.
机译:这项研究的目的是比较艾滋病毒感染者和未感染者梅毒治疗的效果。在2003年1月至2005年6月间,在英国的三个泌尿泌尿科诊所对被诊断为早期梅毒的患者进行了观察性研究。在没有再次感染史的情况下,最初的性病研究实验室(test)(VDRL)滴度未能在12个月内降低四倍被认为是治疗失败。在研究期间,已诊断出190名未感染HIV的艾滋病毒和129名感染了HIV的患者,对梅毒进行了24个月随访的梅毒诊断为梅毒的161名(84%)未感染HIV和100名(77.5%)HIV阳性患者结果包括在研究中(P = 0.10)。在24个月内,分别有381和508例HIV感染和未感染患者的随访。一名艾滋病毒感染患者被诊断出患有神经梅毒。 12个月后,治疗了102名(63%)未感染HIV的患者和76名(70%)被HIV感染的患者(P = 0.04)。在Cox比例风险模型中,VDRL滴度大于1:6会与12个月后的成功治疗相关(风险比[HR] 1.011; 95%置信区间[CI]为1.004-1.019; P = 0.002)。免疫球蛋白M酶测定阴性的患者在12个月后成功治疗的可能性较小(HR 0.676 [95%CI 0.518-0.883]; P = 0.004)。 HIV血清状况,年龄,性别和治疗方案与治疗成功无关。总之,艾滋病毒的血清状况在梅毒治疗的结果中不起作用。在一部分感染了HIV的患者中,治疗失败是由于VDRL滴度下降较慢,而不是对治疗无反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号